| scholarly article | Q13442814 |
| P50 | author | Norbert Sewald | Q39474210 |
| Kristian M Müller | Q88175798 | ||
| Rebecca C Feiner | Q91325001 | ||
| Isabell Kemker | Q91882928 | ||
| P2860 | cites work | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 | Q26771417 |
| Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
| N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists | Q30580638 | ||
| Integrin alpha(v)beta(3)-Targeted Cancer Therapy | Q33983773 | ||
| The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation | Q34188235 | ||
| Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids | Q34567390 | ||
| A High-Throughput Fluorescence Assay to Determine the Activity of Tryptophan Halogenases | Q36130188 | ||
| Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs | Q36597647 | ||
| Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. | Q37383038 | ||
| Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives | Q37774596 | ||
| RGD-mediated delivery of small-molecule drugs. | Q38732486 | ||
| Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). | Q39011647 | ||
| Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. | Q39198665 | ||
| Questioning the Use of PEGylation for Drug Delivery. | Q40513057 | ||
| Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis | Q40632272 | ||
| Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion | Q41157466 | ||
| A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins. | Q41195862 | ||
| RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways. | Q43821769 | ||
| Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. | Q45213256 | ||
| Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. | Q46079015 | ||
| Development of fluorescent aryltryptophans by Pd mediated cross-coupling of unprotected halotryptophans in water | Q46335630 | ||
| Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides | Q49177235 | ||
| Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting. | Q55338721 | ||
| Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy. | Q55425612 | ||
| NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging | Q79135180 | ||
| Polyethylene glycol aggregates in water formed through hydrophobic helical structures | Q84168628 | ||
| Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin αvβ3 Receptor Using a "Random Design" Approach | Q90961758 | ||
| Cyclization of RGD Peptides by Suzuki-Miyaura Cross-Coupling | Q91882935 | ||
| Fluorogenic Diversification of Unprotected Bromotryptophan by Aqueous Mizoroki-Heck Cross-Coupling | Q91994501 | ||
| Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate | Q93212254 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 496-499 | |
| P577 | publication date | 2019-10-25 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Size-Dependent Cellular Uptake of RGD Peptides | |
| P478 | volume | 21 |
| Q92677533 | Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates | cites work | P2860 |
Search more.